{
    "eid": "2-s2.0-84956944542",
    "title": "Emerging Agents for the Management of Nephrotic Syndrome: Progress to Date",
    "cover-date": "2016-02-01",
    "subject-areas": [
        {
            "$": "Pharmacology (medical)",
            "@code": "2736"
        },
        {
            "$": "Pediatrics",
            "@code": "2735"
        }
    ],
    "keywords": [],
    "authors": [
        "Keisha L. Gibson"
    ],
    "citedby-count": 5,
    "ref-count": 36,
    "ref-list": [
        "Time trends and ethnic patterns of childhood nephrotic syndrome in Yorkshire, UK",
        "Grading evidence and recommendations for clinical practice guidelines in nephrology. A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)",
        "Treatment of steroid-sensitive nephrotic syndrome: New guidelines from KDIGO",
        "Treatment of steroid-resistant nephrotic syndrome in children: New guidelines from KDIGO",
        "High incidence of initial and late steroid resistance in childhood nephrotic syndrome",
        "Changing patterns in the histopathology of idiopathic nephrotic syndrome in children",
        "High incidence of focal segmental glomerulosclerosis in nephrotic syndrome of childhood",
        "The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A",
        "Tumor necrosis factor-\u03b1 production from mononuclear cells in nephrotic syndrome",
        "Elevated Levels of Tumor Necrosis Factor-\u03b1 in the Nephrotic Syndrome in Humans",
        "Effect of add-on pentoxifylline on proteinuria in membranous glomerulonephritis: A 6-month placebo-controlled trial",
        "Pentoxifylline in the Treatment of Refractory Nephrotic Syndrome Secondary to Lupus Nephritis",
        "Pentoxifylline for diabetic kidney disease",
        "Pentoxifylline ameliorates proteinuria through suppression of renal monocyte chemoattractant protein-1 in patients with proteinuric primary glomerular diseases",
        "Monocyte chemoattractant protein-1 (MCP-1) in the kidney: Does it more than simply attract monocytes?",
        "Emerging therapies for chronic kidney disease: What is their role?",
        "Blockade of p38\u03b1 MAPK ameliorates acute inflammatory renal injury in rat anti-GBM glomerulonephritis",
        "Inhibition of p38 mitogen-activated protein kinase is effective in the treatment of experimental crescentic glomerulonephritis and suppresses monocyte chemoattractant protein-1 but not IL-1\u03b2 or IL-6",
        "Role of p38 mitogen-activated protein kinase activation in podocyte injury and proteinuria in experimental nephrotic syndrome",
        "The endothelin system and endothelin receptor antagonists",
        "Endothelial mitochondrial oxidative stress determines podocyte depletion in segmental glomerulosclerosis",
        "\u03b2-arrestin-1 drives endothelin-1-mediated podocyte activation and sustains renal injury",
        "Inhibition of tumor necrosis factor and subsequent endotoxin shock by pirfenidone",
        "Improved mitochondrial function underlies the protective effect of pirfenidone against tubulointerstitial fibrosis in 5/6 nephrectomized rats",
        "Pirfenidone is renoprotective in diabetic kidney disease",
        "A pilot study in patients with established advanced liver fibrosis using pirfenidone [4]",
        "Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis",
        "A double-blind, randomized, controlled study of oral pirfenidone for treatment of secondary progressive multiple sclerosis",
        "Pirfenidone: In idiopathic pulmonary fibrosis",
        "Pirfenidone slows renal function decline in patients with focal segmental glomerulosclerosis",
        "Pirfenidone for diabetic nephropathy",
        "Generation of biologically active linear and cyclic peptides has revealed a unique fine specificity of rituximab and its possible cross-reactivity with acid sphingomyelinase-like phosphodiesterase 3b precursor",
        "Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome",
        "Induction of B7-1 in podocytes is associated with nephrotic syndrome",
        "Abatacept in B7-1-positive proteinuric kidney disease"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "affilname": "Chulalongkorn University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Chapel Hill",
            "affilname": "UNC School of Medicine",
            "affiliation-country": "United States"
        }
    ],
    "funding": []
}